Today: 20 March 2026
Subscribe
Browse Category

NASDAQ:ENVB 10 December 2025

Top U.S. Stock Gainers After the Bell on December 10, 2025: ASPC, BBGI, ENVB, PLAB, IRBT, AHT Lead Fed‑Day Rally

Top U.S. Stock Gainers After the Bell on December 10, 2025: ASPC, BBGI, ENVB, PLAB, IRBT, AHT Lead Fed‑Day Rally

The Federal Reserve cut its benchmark rate by 25 basis points Wednesday, marking its third reduction of 2025. The Dow rose 1.05%, the S&P 500 gained 0.67%, and the Nasdaq added 0.33%. Small- and mid-cap stocks saw sharp moves, with Beasley Broadcast Group surging nearly 390%. After-hours trading kept ASPC and ENVB among the top gainers.
10 December 2025
········
Top U.S. Stock Gainers Today (Dec. 10, 2025): ASPC, BBGI, ENVB, PLAB, IRBT & AHT Rocket on Fed Day

Top U.S. Stock Gainers Today (Dec. 10, 2025): ASPC, BBGI, ENVB, PLAB, IRBT & AHT Rocket on Fed Day

A SPAC III Acquisition Corp. surged 267% and Beasley Broadcast Group jumped 224% Wednesday, leading U.S. stock gainers as the S&P 500 stayed flat ahead of a key Federal Reserve decision. Enveric Biosciences rose 79% on patent news. The Fed is expected to cut rates by 25 basis points, with attention on its 2026 rate outlook.
10 December 2025
······
Enveric Biosciences (ENVB) Stock Surges on Patent Win: News, Forecast & Analysis as of December 10, 2025

Enveric Biosciences (ENVB) Stock Surges on Patent Win: News, Forecast & Analysis as of December 10, 2025

Enveric Biosciences shares surged over 70% in after-hours trading December 9, reaching around $10.29 after closing at $5.92, following news of a U.S. patent allowance for its EVM301 mental-health drug series. Pre-market quotes early December 10 ranged from $10.48 to $12.45 amid heavy volatility. The stock had fallen about 90% over the past year. The new patent covers both composition and method-of-use claims.
10 December 2025
Top U.S. Stock Gainers Today (Dec. 10, 2025): ASPC, ENVB, BDRX, HSPO, BRZE Surge Ahead of Fed Decision

Top U.S. Stock Gainers Today (Dec. 10, 2025): ASPC, ENVB, BDRX, HSPO, BRZE Surge Ahead of Fed Decision

A SPAC III Acquisition (ASPC) surged over 100% pre-market Dec. 10, trading between $25 and $31 after sharp gains in after-hours. Enveric Biosciences (ENVB) and Biodexa Pharmaceuticals (BDRX) also posted triple- and double-digit percentage gains. Major U.S. index futures were little changed ahead of the Federal Reserve’s final 2025 rate decision. Speculative micro-caps and SPACs led early trading volatility.
10 December 2025
··········
Top Pre‑Market Gainers Today, December 10, 2025: ASPC, ENVB, BDRX and APVO Lead Fed‑Day Frenzy

Top Pre‑Market Gainers Today, December 10, 2025: ASPC, ENVB, BDRX and APVO Lead Fed‑Day Frenzy

A SPAC III Acquisition Corp. surged over 219% pre-market Wednesday, leading U.S. gainers as traders await the Federal Reserve’s final 2025 policy decision. Nasdaq 100, S&P 500, and Dow futures ticked higher, while the 10-year Treasury yield hovered near 4.18%. Silver traded above $61 an ounce. Other top pre-market movers included Enveric Biosciences, Biodexa Pharmaceuticals, and Ashford Hospitality Trust.
10 December 2025
··········

Stock Market Today

  • ASX Set to Dip as Middle East Tensions Boost Oil Prices; Premier Investments Reports Lower H1 Earnings
    March 19, 2026, 9:22 PM EDT. Australian shares are expected to decline on Friday amid volatile energy markets triggered by Middle East strikes that briefly pushed Brent crude to $119 a barrel. The S&P 500 and Nasdaq each dropped 0.3%, while the Dow fell 0.4% overnight. Investors are also focused on Australia's upcoming consumer price index report. Premier Investments (ASX:PMV) posted fiscal first-half earnings of AU$0.6351 per share on AU$460.3 million revenue, down from AU$0.7307 earnings on AU$465.2 million a year earlier. Flight Centre Travel Group (ASX:FLT) acquired UK agency Fresh Approach, expanding its FCM meetings-and-events operations. The ASX benchmark closed down 1.7% at 8,497.80 on Thursday.
Go toTop